Your Good Partner in Biology Research

重组蛋白

产品名称 货号 规格
Recombinant Shewanella halifaxensis Serine--tRNA ligase (serS) CSB-YP538779SYU
CSB-EP538779SYU
CSB-BP538779SYU
CSB-MP538779SYU
CSB-EP538779SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 30S ribosomal protein S6 (rpsF) CSB-YP538780SYU
CSB-EP538780SYU
CSB-BP538780SYU
CSB-MP538780SYU
CSB-EP538780SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis 23S rRNA (uracil (747)-C (5))-methyltransferase RlmC CSB-YP538781SYU
CSB-EP538781SYU
CSB-BP538781SYU
CSB-MP538781SYU
CSB-EP538781SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella halifaxensis Formate--tetrahydrofolate ligase (fhs), partial CSB-YP538782SYU
CSB-EP538782SYU
CSB-BP538782SYU
CSB-MP538782SYU
CSB-EP538782SYU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Adenylosuccinate synthetase (purA) CSB-YP538783FFC
CSB-EP538783FFC
CSB-BP538783FFC
CSB-MP538783FFC
CSB-EP538783FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP538784FFC
CSB-EP538784FFC
CSB-BP538784FFC
CSB-MP538784FFC
CSB-EP538784FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Anthranilate phosphoribosyltransferase (trpD) CSB-YP538785FFC
CSB-EP538785FFC
CSB-BP538785FFC
CSB-MP538785FFC
CSB-EP538785FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Tryptophan synthase beta chain (trpB) CSB-YP538786FFC
CSB-EP538786FFC
CSB-BP538786FFC
CSB-MP538786FFC
CSB-EP538786FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Phosphoglucosamine mutase (glmM) CSB-YP538787FFC
CSB-EP538787FFC
CSB-BP538787FFC
CSB-MP538787FFC
CSB-EP538787FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Glycerol kinase (glpK) CSB-YP538788FFC
CSB-EP538788FFC
CSB-BP538788FFC
CSB-MP538788FFC
CSB-EP538788FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia 50S ribosomal protein L7/L12 (rplL) CSB-YP538789FFC
CSB-EP538789FFC
CSB-BP538789FFC
CSB-MP538789FFC
CSB-EP538789FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia RNA pyrophosphohydrolase (rppH) CSB-YP538790FFC
CSB-EP538790FFC
CSB-BP538790FFC
CSB-MP538790FFC
CSB-EP538790FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia 10 kDa chaperonin (groS) CSB-YP538791FFC
CSB-EP538791FFC
CSB-BP538791FFC
CSB-MP538791FFC
CSB-EP538791FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP538792FFC
CSB-EP538792FFC
CSB-BP538792FFC
CSB-MP538792FFC
CSB-EP538792FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia tRNA pseudouridine synthase B (truB) CSB-YP538793FFC
CSB-EP538793FFC
CSB-BP538793FFC
CSB-MP538793FFC
CSB-EP538793FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia tRNA 2-thiocytidine biosynthesis protein TtcA 1 (ttcA1) CSB-YP538794FFC
CSB-EP538794FFC
CSB-BP538794FFC
CSB-MP538794FFC
CSB-EP538794FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP538795FFC
CSB-EP538795FFC
CSB-BP538795FFC
CSB-MP538795FFC
CSB-EP538795FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP538796FFC
CSB-EP538796FFC
CSB-BP538796FFC
CSB-MP538796FFC
CSB-EP538796FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Chaperone protein DnaK (dnaK), partial CSB-YP538797FFC
CSB-EP538797FFC
CSB-BP538797FFC
CSB-MP538797FFC
CSB-EP538797FFC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Francisella philomiragia subsp. philomiragia Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP538798FFC1
CSB-EP538798FFC1
CSB-BP538798FFC1
CSB-MP538798FFC1
CSB-EP538798FFC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用资源

什么是重组蛋白?

重组蛋白是一种可操纵的蛋白质形式,可以通过多种方式产生大量蛋白质、修改基因序列和制造有用的商业产品。重组蛋白的技术资源在重组蛋白的开发过程中,除了表达系统之外,还面临着一系列令人困惑的选择,如表达载体的选择、表达蛋白的长度(全长或部分)、是否带标签等。在生产重组蛋白时,你必须做出很多决定。如果你选择的明智,你将获得高质量的重组蛋白,后续的实验更有可能成功。但是如果你做了错误的决定,你可能得不到你所需要的重组蛋白或者重组蛋白的质量和纯度不符合要求。在这里,来自CUSABIO的蛋白表达工程师根据他们开发重组蛋白的经验总结出了几个有用的提示,可以帮助你做出明智的决策。

第一条:重组蛋白的生产,在这篇文章中,我们旨在阐明重组蛋白的定义以及如何生产重组蛋白。

第二条:如何选择合适的表达载体?

表达载体是一种DNA分子,它携带特定的基因进入宿主细胞,并利用细胞的蛋白质合成机制来产生由该基因编码的蛋白质。表达载体可使外源基因在宿主细胞中高效表达,经过多年的发展,表达载体已成为一种成熟而受欢迎的生物技术。在重组蛋白生产过程中是一种基本成分。正如标题所示,本文主要总结了几个有用的技巧来选择合适的表达载体。

第三条:如何表达具有生物活性的蛋白质?

根据重组蛋白的不同应用,对其生物活性有不同的要求。但是我们如何确保蛋白质的产生具有生物活性呢?本文将围绕这个主题,并提供一些解决方案。除了以上文章,我们还收集了一些重组蛋白的常见问题。您可以单击以下链接查看。/technology-91.html。此外,我们还为我们的客户提供重组蛋白表达服务,您可以点击这里获取更多信息。注:如果您对CUSABIO的蛋白质有任何疑问,涉及到蛋白质的价格、交货、质量等,您可以点击橙色按钮为我们在线留言。

引用资料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>